L’outil de licence Creative Commons du formulaire de soumission ne fonctionne pas actuellement. Pour ajouter une licence CC à votre thèse ou publication, contactez ruor@uottawa.ca après le dépôt. -- The Creative Commons licence tool in the submission form is currently unavailable. To apply a CC licence to your thesis or publication, contact ruor@uottawa.ca after the deposit.

Recherche uO, le dépôt numérique de l'Université d'Ottawa, réunit le matériel de recherche et d'enseignement créé par notre communauté universitaire et nos partenaires. Le savoir de l'Université est ainsi disponible à long terme et en accès libre, ce qui lui procure de la visibilité et facilite sa diffusion.

Nouveaux dépôts

  • Type d'Item : Item ,
    Comparative Efficacy of Novel Non-steroidal Topical Therapies for Atopic Dermatitis: A Systematic Review and Network Meta-analysis
    (2026-11-10) Gupta, Sana; Bell, Madison; Liu, Laurel; Xiong, Grace; Abu-Hilal, Mohannad
    Abstract Introduction Despite the availability of several non-steroidal topical therapies for atopic dermatitis (AD), their comparative speed of clinical response remains unclear. This meta-analysis compared the efficacy of novel non-steroidal topical therapies for AD. Methods Four databases were searched for randomized controlled trials (RCTs) evaluating topical difamilast 1% twice daily (BID), tapinarof 1% once daily (QD), ruxolitinib 1.5% BID, roflumilast 0.05% or 0.15% QD in patients with AD. Outcomes included Investigator’s Global Assessment Treatment Success (IGA-TS) and 50%, 75% and 90% improvement in Eczema Area and Severity Index (EASI-50, EASI-75 and EASI-90) at weeks 1, 2, 4 and 8. Frequentist random-effects network meta-analyses estimated odds ratios (ORs) and 95% confidence intervals (CIs), primarily comprising indirect comparisons between non-steroidal topicals using a common vehicle comparator. Results Twenty-two RCTs (5843 participants) were included. Ruxolitinib demonstrated the highest odds of IGA-TS versus vehicle at week 2 (OR 8.94; 95% CI 5.28–15.12), 4 (OR 9.03; 95% CI 6.27–13.01) and 8 (OR 9.03; 95% CI 6.52–12.50), along with EASI-75 and EASI-90. Difamilast demonstrated favourable EASI-75 (OR 5.34; 95% CI 3.51–8.12) and EASI-90 (OR 6.71; 95% CI 3.79–11.89) responses versus vehicle at week 4; later data were unavailable. Conclusions Efficacy profiles varied across novel non-steroidal topical therapies, with ruxolitinib demonstrating the strongest and most consistent relative efficacy estimates. Response magnitude and timing remain important considerations when selecting topical AD treatments.
  • Type d'Item : Item ,
    Equity-focused theories, models, and frameworks in implementation science: a scoping review and critical appraisal
    (2026-08-19) Crump, Laura; Semenic, Sonia; Ahun, Marilyn N.; Doyle, Sheena; Stuart, Rebecca; Weight, Charlene; Froehlich-Chow, Amanda; King, Alexandra; Etherington, Cole; Welch, Vivian; Shelton, Rachel C.; Presseau, Justin; Fontaine, Guillaume
    Abstract Background Implementation science theories, models and frameworks (TMFs) can guide implementation research and practice to address widening inequities in healthcare access, quality, and health outcomes. This scoping review aimed to map and critically appraise implementation science TMFs explicitly created or adapted to advance health equity. Methods We conducted a scoping review using Joanna Briggs Institute guidance. We searched MEDLINE, CINHAL, and five implementation science and equity journals from inception to May 20, 2025. Eligible records were primary descriptions of (i) implementation science TMFs purposely built to advance health equity or (ii) equity-focused adaptations of existing implementation science TMFs. Applications of TMFs in research or practice and non-implementation science TMFs were excluded. Two reviewers independently screened titles/abstracts then full texts in Covidence with consensus adjudication. Data were charted on a standardized form, and each TMF underwent duplicate critical equity appraisal against eight a priori criteria with an equity expert providing methodological input. Findings were summarized narratively and in evidence tables. Results From 6,012 records, 42 TMFs were included (23 adaptations of existing TMFs, 19 purpose-built), and most (69%) were published after 2020. Geographic provenance was heavily skewed with 67% originating in the United States; none originated in low-income countries. Most included TMFs aimed to orient the implementation process (45%) or assess determinants (23%). Assessment of TMFs according to eight equity criteria showed uneven coverage: 90% explicitly name health inequities; 88% suggest incorporating lay knowledge; 86% promote cultural responsiveness; 64% emphasize two-way learning and relationship building, and 60% consider structural determinants. However, only 45% propose concrete community co-ownership mechanisms; 40% outline strategies to mitigate inequities; and 40% offer processes addressing structural barriers. Seven TMFs (17%) covered all eight equity criteria. Conclusions Equity-focused TMFs are proliferating, but most originate in high-income countries and few provide concrete guidance for addressing structural determinants of health inequities. Before use, researchers and practitioners should critically appraise candidate TMFs with communities and equity experts, co-adapt them to local contexts, and, where necessary, extend them to strengthen underdeveloped domains such as structural change and community co-ownership. Registration N/A.
  • Type d'Item : Item ,
    Artificial intelligence in implementation science and practice: a living scoping review
    (2026-08-14) Fontaine, Guillaume; Lalla, Olivia D.; Laritz, Rachael; Durran, Jeremiah; Zhang, Chi; Chan, Jeffery; Crump, Laura; Matra Putra, Alenda D.; Abbasgholizadeh-Rahimi, Samira; An, Ruopeng; Beidas, Rinad S.; Fahim, Christine; Geng, Elvin; Graham, Ian D.; Hastings, Janna; Lambert, Sylvie D.; Légaré, France; Michie, Susan; Powell, Byron J.; Presseau, Justin; Elias, Joseph; Rudge, Thomas; Straus, Sharon E.; Thomas, James; Welch, Vivian; Taylor, Natalie
    Abstract Background Artificial intelligence (AI) encompasses computational systems that perform tasks typically requiring human intelligence, including machine learning, generative AI, and agentic applications. The use of AI to support implementation activities is growing, but its applications and evaluation remain poorly characterised. We conducted the first cycle of a living scoping review to identify how AI is being used and evaluated across implementation science and practice. Methods We followed JBI and Cochrane guidance and reported findings per PRISMA-ScR and PRISMA-LSR. We searched six databases through April 6, 2026, and included sources describing or evaluating AI to support implementation research or practice activities. We excluded adjacent uses such as knowledge synthesis automation. We extracted study characteristics, AI approaches, implementation tasks, evaluation methods, outcomes, and risks, and synthesised findings descriptively. Results We identified 7,203 records and included 40 sources, 34 (85%) of which were published since 2021. Thirty-one sources described, developed, or evaluated a specific AI system, comprising 22 primary research articles, three protocols, three conference abstracts, and three other sources. The remaining nine conceptual, methodological, framework or review articles discussed potential applications of AI in implementation science. Across all 40 sources, AI was most often used or proposed to support evaluation (25/40), implementation strategy selection and tailoring (23/40), barrier and facilitator assessment (21/40), and implementation monitoring (20/40). Among the 31 sources involving a specific AI system, the use of conventional machine learning was most common (10/31), followed by generative AI (7/31), multicomponent AI systems or studies comparing AI approaches (5/31), and non-generative deep learning (3/31). Implementation-related outcomes were reported or prospectively specified in 25/31 sources, technical performance in 19/31, human-centred outcomes in 12/31, time or efficiency in 10/31, clinical or health system outcomes in 9/31, equity in 3/31, and cost or resource outcomes in 2/31. Risks were discussed in about half of sources, although assessment of harms and environmental or societal consequences was rare. Conclusions AI is in a nascent stage of supporting implementation science and practice. Reported use is narrow and methodologically underdeveloped, and much routine use is likely unpublished. The field needs rigorous, comparative, prospective, and equity-attentive research to establish whether and how AI improves implementation methods, processes, and outcomes. Registration Open Science Framework, May 2025: https://doi.org/10.17605/OSF.IO/2Q5DV
  • Type d'Item : Item ,
    Association of mental health encounters in medical school with physician specialty in Ontario, Canada
    (2026-08-17) Moledina, Aliza; Brouwers, Melissa; Myran, Daniel T.; Tanuseputro, Peter; Grubic, Nicholas; Talarico, Robert; Sood, Manish M.; Gibb, Maya; Maskerine, Courtney; Kendall, Claire E.
    Abstract Background Mental health concerns among medical students are common and may influence specialty selection and early-career practice patterns. However, their potential impact on physician workforce distribution across specialties is not well understood. Methods We conducted a population-based cohort study of physicians newly registered with the College of Physicians and Surgeons of Ontario (CPSO) between 2008 and 2018. We linked CPSO demographic data with ICES (formerly known as the Institute for Clinical and Evaluative Sciences) health administrative databases using unique encoded identifiers. Mental health encounters were defined as ≥ 1 healthcare encounter for mental health or substance use in the two years prior to medical school graduation. The outcome was the first specialty listed at initial CPSO registration, reflecting physicians’ earliest registered specialty upon entry into practice. We used multivariable logistic regression to examine the association between mental health encounters and specialty (with Family Medicine as the referent group) adjusting for age, sex, language proficiency, medical school, rurality and neighbourhood income quintile at age 16. Results Among 7105 physicians (median age 26 years, 56% female), 46% entered Family Medicine (n = 3261). Compared with Family Medicine, physicians with a prior mental health encounter had lower odds of entering acute care specialties including Emergency Medicine/Critical Care (OR 0.48; 95% CI 0.35, 0.67), Surgery (OR 0.63; 95% CI 0.52, 0.77), Anaesthesia (OR 0.67; 95% CI 0.50, 0.91) and Internal Medicine/Neurology (OR 0.68; 95% CI 0.58, 0.80), and higher odds of entering Psychiatry (OR 1.55; 95% CI 1.22, 1.97). Conclusion Mental health encounters near medical school graduation are associated with early-career specialty registration. These findings may reflect differences in perceived or actual residency support, lifestyle considerations, or training demands across specialties. Clinical trial number Not applicable.
  • Type d'Item : Item ,
    Relative abundance of a gut-derived Lancefieldella parvula strain is associated with severe inflammation in IBD
    (2026-08-14) Weerasingha, Sasanka; Yan, Austin; Butcher, James; Mack, David R.; Stintzi, Alain
    Abstract Background Lancefieldella parvula (previously known as Atopobium parvulum) has been associated with inflammatory bowel disease (IBD); however, prior in vivo studies relied on an oral-derived reference strain rather than intestinal clinical isolates, limiting interpretation of its role in gut inflammation. To address this gap, we isolated a clinical strain of L. parvula (designated L. parvula TI19E08) from a mucosal luminal aspirate of an ulcerative colitis (UC) participant. We developed a strain-specific quantitative PCR assay to quantify its abundance across anatomical sites in treatment-naïve pediatric IBD participant (UC and Crohn’s disease (CD)) and examined its relationship with site-specific endoscopic inflammation severity. Results We demonstrated that the relative abundance of L. parvula TI19E08 increased with increasing local inflammation severity. In UC, both strain-specific and total L. parvula levels were strongly correlated with inflammation severity, particularly in the proximal colon. In CD patients, strain-level associations were most pronounced in the terminal ileum, which is consistent with the disease distribution. Conclusion This study characterizes an intestinal L. parvula isolate and demonstrates that strain-level expansion correlates with disease severity across IBD subtypes and anatomical regions. These findings identify L. parvula TI19E08 as a candidate mucosal marker of inflammation severity in IBD patients.